• En
  • Ru
  • Kr
  • Jp
  • Cn
  • Fr
  • It
  • De
  • Sp
  • Pt
  • Tr
  • Pl
  • Ar
  • Ph
  • Id
  • Hi
  • Nl
  • Vi
  • Cs
  • Gr
  • Ro
  • Hu
  • Dk
  • He
  • Hr
  • Sr
  • Lv
Sign in Sign up
#Healthcare All projects

FarmaTrust: the most efficient global tracking system

Using Blockchain and Artificial Intelligence to save lives and create efficiencies

stage Ended crowdsale

4.0 Rating

by 4 users


    • Employees18


    December, 2016

    Developed first version
    Full stack developers onboarded
    Establish architecture and design

    December, 2017

    Private pre-sale


    man Lord Anthony ST John of Blesto


    Lord Anthony St John of Bletso is a Crossbench/Independent Member of the House of Lords, he was brought up in South Africa, where he qualified as a solicitor. After completing his Masters in Law at London University, he worked as legal counsel for Shell and then an oil analyst/specialist sales for several institutions in the City, including Merrill Lynch, focusing on Sub-Saharan African and the Far East. He is currently Chairman of Strand Hanson and Integrated Diagnostic Holdings plc and serves on the board of several public and private companies and has recently become a member of the House of Lords Ad Hoc Select Committee on Artificial Intelligence. His specialist interests are cyber security, financial services and life sciences. Since 1998 he has served as Extra Lord in Waiting to HM The Queen and is a Trustee of 6 charities, mostly focused on education and wildlife conservation.

    man Raja Sharif


    Raja Sharif is the Founder and CEO of FarmaTrust. He is driving the company’s vision and mission of protecting the vulnerable by eliminating deadly counterfeit medications on a global scale. Raja has managed a number of technology and media projects worldwide for some of the best known brands, including British Telecom and Al Jazeera. He is a Barrister by background, having worked as General Counsel and company secretary managing legal affairs, risk and good corporate governance.

    man Peter Bryant


    As COO of FarmaTrust, Peter is planning, coordinating and managing the company’s strategic business operations towards achieving the vision and mission of protecting the vulnerable by eliminating deadly counterfeit medications on a global scale. Before joining the board of FarmaTrust, Peter has successfully created and grown businesses, realised value through trade sales and been involved in a Management Buy In (MBI) of Guardian IT which later resulted in a full market flotation on the London Stock Exchange. He is familiar with obligations of operating a company, directors duties and holds a number of Chairman and Non-executive directorships of technology companies.

    man Shahnawaz Aziz


    Shahnawaz is a senior technologist with over 21 years of IT experience in managing, architecting, designing and developing software applications across Financial Services, Investment Banking, Shipping & Logistics and Government projects. He has been involved in blockchain for a number of years.Shahnawaz has a visionary ability to solve complex solutions using Blockchain, Social, Cloud, Mobile, AI and Big Data. Recently he successfully launched HD bitcoin wallet and blockchain platform, showcased via nTrust.com. He also delivered global bitcoin trading platform earlier this year.He also has a number of patents including patent rights assigned: ``Secure Multiparty loss resistant Storage and Transfer of Cryptographic Keys for blockchain

    man Steve Mcavoy

    Head of Implementation

    Steve comes from a software engineering background. His expertise lies in the installation of large scale systems from the point of analysis, implementation and then testing. He has worked for some of the largest brand names in the financial sector such as Investec, Royal Bank of Scotland, Lloyds, UBS and Barclays, ensuring the integrity of data and meeting service level agreements. He has also worked in the governmental and defense sectors.


    man David Allen Cohen

    David Allen Cohen

    David A. Cohen is the Chief Technology Adviser at FarmaTrust. David is internationally renowned for his pioneering work in the Decentralized Software industry, Digital Currency and Blockchain industry. David was named as one of the Top 100 Movers and Shakers in the SmartGrid by Greentech Media. He was the founder and CEO of Infotility where he pioneered the “Grid Edge” creating the industries first artificial intelligence-based software platform - GridAgents™. David is a thought leader, speaking in venues such as MIT, TEDx, Consensus, Blockchain 100X and Singularity University. He is an expert on Blockchain, Artificial Intelligence, Cybersecurity, and Edge Computing. He is a former IOTA Foundation member. David is currently founder and Chairman of dcntral, a blockchain-based Cybersecurity company as well as advisor on the Machine Economy for Hashgraph.

    man Stephen Cole

    Advisory Board Member

    Stephen Cole is a well known international television news anchor for almost three decades. He has conducted network interviews with Presidents, Prime Ministers and film stars. He hosted and produced the Oscars Special programme on BBC World for six years. Stephen successfully launched 4 of the world's main news channels, Sky News, CNN International, BBC World and Al Jazeera International. Stephen is also Chairman and Moderator at World Economic Forum at Davos, Eurasian Media Forum in Astana and the World Science Forum. Stephen is a judge at the British Academy of Film and Television Arts, a Board member of the Global Thinkers Forum and a former Director of the world-famous Premiership London Welsh rugby club. He is currently Chairman of the Institute of Diplomacy and Business.

    man Chris Saynor

    Advisory Board Member

    Chris pioneers innovative marketing strategies to reach the supply chain and logistics industry. As the former CEO of eyefortransport, Chris developed eft into the world’s leading logistics business intelligence company, organizing CEO-level events around the world and specializing in cutting edge supply chain research. Chris is now a regular keynote speaker and event Chairman at Supply Chain conferences in both Europe and North America the world. Chris also sits on the Advisory Board of Lanetix, a San Francisco technology company that provides workflow and collaboration solutions to the Logistics industry. He is also an active Advisor to WTA, a 104 year old London based Logistics company.

    man Professor Timothy Mackey

    Advisory Board Member

    Tim Ken Mackey is the Director of the Global Health Policy Institute, an Associate Professor of Anesthesiology and Global Public Health at UC San Diego School of Medicine, and is the Director for Healthcare Research & Policy at UC San Diego Extension. He holds a BA in Political Science-International Relations, a Masters Degree in Health Policy & Law and also earned his PhD in Global Public Health from the joint doctoral program at UC San Diego - San Diego State University.

    man Kate Enright

    Advisory Board Member

    Kate completed her pharmacy training with Pfizer, before commissioning into the British Army in 2006. Achieving the rank of Major, her diverse roles included tours of Iraq, Afghanistan and British Forces Cyprus where, as Head of Medical Logistics, she led the pharmaceutical supply chain planning for the Volcanic Ash Cloud crisis.

    Crowdsale details

    Distribution of tokens
    • Crowdsale (60%)
    • Team Allocation (10%)
    • Advisors (10%)
    • Incentives and retention (10%)
    • Marketing (5%)
    • FarmTrus Operational (5%)
    Budget allocation
    • Technology and product development (40%)
    • Security (10%)
    • Marketing (10%)
    • Business Development (10%)
    • Audit and Compliance (10%)
    • Accounting (10%)
    • Overhead (5%)
    • Legal (5%)
    Details Indicators
    Token Symbol FTT
    Full Token Name FarmaTrust token
    Pre-crowdsale Start February 15th, 00:00 GMT+03:00
    Pre-crowdsale End Hard cap is reached or March 15th, 00:00 GMT+03:00
    Pre-crowdsale Hard Cap Fixed, $7000000
    Crowdsale Start March 15th, 00:00 GMT+03:00
    Crowdsale End Hard cap is reached or April 15th, 00:00 GMT+03:00
    Crowdsale Hard Cap Fixed, $20250000
    Domain registration date 2018-01-05
    Domain owner Raja Sharif


    0.00010870 ETH per token
    20% discount off the original token price for a cap of 1 week or 75m tokens,
    whichever comes first.
    10% discount off the original token price for a cap of 1 week or 125m tokens,
    whichever comes first.

    Bonus Dates Minimum purchase amount
    20% February 15 — March 15, 2018

    Accepted currency

    • Ethereum

    Rate the project

    Estimate the project on a five-point scale or switch to the simple scale

    Five-point scale Simple scale

    Relevance of the problem and Market size

    1 2 3 4 5

    Product competitiveness

    1 2 3 4 5

    Founders, Team & Advisors

    1 2 3 4 5

    Budget allocation and roadmap

    1 2 3 4 5

    Token economy, Tokenization & Business model

    1 2 3 4 5

    Distribution & Lock up of tokens, Discounts for early buyers

    1 2 3 4 5

    Summary rate the project

    1 2 3 4 5

    Rate the project by other users

    Alexandr Gonchar May 18, 2018
    Rating of project


    The platform uses blockchain technology and artificial intelligence to track the supply chain of medicines from the manufacturer to the client. This is an interesting and relevant development that will help in the fight against counterfeit medicines and save a thousand lives.

    Risks and disadvantages

    There are no obvious minuses in the project and it is rather interesting and useful especially for developing countries and poorly developed regions. Blockchain technology allows you to fully control the supply chain and track their distribution around the world in an interactive mode.


    The project certainly has prospects and can become successful. The lack of competition in this sector and the urgency of the problem (which is difficult to solve by other methods), can create an additional impulse for the rapid development of the project and its integration into the market of medicinal industry.

    Andrew Robinson April 17, 2018
    Rating of project


    The project website contains detailed information on the ICO and video materials that will help potential investors quickly learn the essence of the project and how it will work. There is a transparent scheme for allocating the budget and freezing the team tokens, it will protect against the reduction in the value of the token after entering the exchange. Also in authoritative sources there are articles about the project, it will help attract more investors.

    Risks and disadvantages

    I think that too many tokens are distributed to the team and advisors, it can raise doubts among investors, since the value of tokens may decrease after entering the exchange. Also there are no agreements with partners and pharmaceutical companies.


    Using blockchain technology, FarmaTrust guarantees that counterfeit medicines will not be sold or consumed around the world. The idea of the project is very useful and promising, but it takes a lot of work, for example, the team needs to conclude many contracts with the pharmaceutical companies. If the team cope with the task, then the project will pay off quickly.

    Denys Serhiichuk April 16, 2018
    Rating of project


    Budget allocation is described informative. Roadmap has precise steps of platform development. Members of the team are active on social media and taking part in project advertising.

    Risks and disadvantages

    There is no demo version of the platform and no agreements with any pharmacy companies.


    The whole idea is great, but pharmacy industry is under governmental control. As a result it can create obstacles for implementation. as Blockchain is not regulated yet in lots of countries.

    Jordan Semanda March 31, 2018
    Rating of project


    The project is very reliable it provides for the distribution of drugs effectively all over the world It also allows the tracking of drugs through their movement from the manufactures to the consumers It provides highly advanced technological verification of drugs verification of drugs fro hospitals and pharmaceuticals which can be done by one using he application on the smartphone. The AI system inbuilt in the system is able to differentiate from the counterfeit and legitimate drugs. It will help on decreasing the number of death rates allover the world because of substandard goods. it will promote inter continental trade. it will increase the number of transactions on the platform hence the value of the token.

    Risks and disadvantages

    The traffic statistics show that a lot is still desired from the creation of ads otherwise this will hinder the prosperity of the project. The project only allows one cyprocurrency which will hinder potential investors with alternate cryptocurrencies.


    The project is good one, the number of counterfeit drugs on the market is increasing each and every day with ineffective solutions to solve this problem This project however provides a long lasting and effective solution to solve the issue not only individuals will adopt this but also governments trying to solve the problem of poor quality drugs on the market. The project has a very wide market base and its target, the global market will be more than ready to adopt the project. This is a highly profitable venture because it focuses at all stages of production which evenly spreads the risk making it a project worth investing.